Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
N
007390
vs
K
KOSPI 200
Over the past 12 months, NatureCell Co Ltd has underperformed KOSPI 200, delivering a return of +20% compared to KOSPI 200's +119% growth.
Stocks Performance
007390 vs KOSPI 200
Performance Gap
007390 vs KOSPI 200
Performance By Year
007390 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
NatureCell Co Ltd
Glance View
NatureCell is a South Korean biotech company best known for work around stem cells and cell-culture products. It develops and sells stem cell-related ingredients, cosmetic products, and medical or research materials tied to regenerative medicine. In simple terms, it sits between laboratory research and commercial products that use cell science. The company makes money by selling these products to cosmetic buyers, research customers, and healthcare-related users, depending on the product line. Its business is different from a plain cosmetics maker because part of its value comes from proprietary cell-culture know-how and stem cell applications, not just branding or packaging. That gives it a role closer to a specialty life-science supplier than a mass consumer goods company. For investors, the key point is that NatureCell’s business depends on scientific development, product approvals, and trust in its technical claims. Its customers are mainly companies and institutions that want niche stem cell or regenerative-medicine products, plus consumers for its cosmetic offerings. This makes the company a hybrid of biotech and beauty, with revenue tied to both regulated medical-style products and consumer-facing sales.